METROPOLITAN LIFE INSURANCE CO/NY - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 90 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.99 and the average weighting 1.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,761
-36.2%
4,3410.0%0.00%0.0%
Q2 2023$21,575
+0.6%
4,3410.0%0.00%0.0%
Q1 2023$21,445
-40.4%
4,341
-24.1%
0.00%
-50.0%
Q4 2022$35,973
-24.9%
5,719
+29.0%
0.00%0.0%
Q3 2022$47,876
-5.3%
4,4330.0%0.00%0.0%
Q2 2022$50,536
+25.1%
4,4330.0%0.00%
+100.0%
Q1 2022$40,385
-84.9%
4,433
-75.3%
0.00%
-75.0%
Q4 2021$267,277
-45.4%
17,914
-6.0%
0.00%
-42.9%
Q3 2021$489,585
-1.5%
19,0500.0%0.01%0.0%
Q2 2021$496,824
-8.4%
19,050
+24.0%
0.01%
-12.5%
Q1 2021$542,349
+35.7%
15,364
-2.9%
0.01%
+33.3%
Q4 2020$399,524
-32.1%
15,829
+1.5%
0.01%
-40.0%
Q3 2020$588,125
-7.7%
15,596
+4.8%
0.01%
-9.1%
Q2 2020$637,376
+151.6%
14,885
+14.2%
0.01%
+120.0%
Q1 2020$253,284
-25.2%
13,0290.0%0.01%
-16.7%
Q4 2019$338,493
-4.7%
13,0290.0%0.01%0.0%
Q3 2019$355,105
+32.4%
13,029
+30.4%
0.01%
+20.0%
Q2 2019$268,204
+5.9%
9,989
+14.0%
0.01%0.0%
Q1 2019$253,309
+1.6%
8,762
-5.3%
0.01%0.0%
Q4 2018$249,2379,2550.01%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$11,310,44515.20%
Wildcat Capital Management, LLC 2,128,370$13,387,4475.11%
TPG GP A, LLC 18,716,306$117,725,5652.31%
EcoR1 Capital, LLC 4,488,200$28,230,7780.86%
Coastal Bridge Advisors, LLC 406,847$2,559,0680.73%
Kynam Capital Management, LP 396,378$2,493,2180.38%
AXQ CAPITAL, LP 73,052$459,4970.32%
Pier Capital, LLC 262,832$1,653,2130.27%
HARBOR CAPITAL ADVISORS, INC. 41,801$262,9280.26%
Woodline Partners LP 2,921,462$18,375,9960.25%
View complete list of ALLOGENE THERAPEUTICS INC shareholders